OLI Technologies, which is on a mission to build radically compact, portable hemodialysis systems for end-stage kidney disease patients, has raised a priced seed round led by Verge HealthTech Fund. This is the most recent of several rounds of funding that the team has raised. 

The team went through the I-Corps Propelus program in 2021, and credits the experience with shaping their trajectory – providing the structure and support to deeply engage in customer discovery and business model development.